360Dx

HTG Molecular Diagnostics Q1 Revenues Jump 200 Percent

May 11, 2018

NEW YORK (GenomeWeb) – HTG Molecular Diagnostics reported on Thursday a 200 percent surge in first quarter revenues driven by its collaborative development services activities with pharma partners.

For the three-month period ended March 31, HTG's revenues climbed to $4.2 million from $1.4 million in the same period the year before.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

HTG Molecular Diagnostics Q1 Revenues Jump 200 Percent

To read the full story....

Breaking News

Cue Health Over-the-Counter COVID-19 Test Gets FDA Emergency Use Authorization

German Stores to Begin Selling COVID-19 Rapid Antigen Tests for Home Use

Abbott Gets FDA EUA for Test That Detects Coronavirus, Three Other Respiratory Infections

Illumina Receives Medical Device Registration in Russia for NextSeq 550 Dx Sequencer, Reagents

DermTech Q4 Revenues Up 31 Percent

In Brief This Week: Abbott Laboratories, LexaGene, Caris Life Sciences, SQI Diagnostics, and More

Featured White Papers

Molecular Multi-Target Assay Design Coupled with Reflex Testing with SARS-CoV-2 Mutations in Mind

Think Globally, Act Locally: The Importance of Coordinated Global and Community Genetic Surveillance Programs

Development and Commercialization of a Novel CRISPR-Based SARS CoV-2 Test

The Post-Vaccine COVID Testing Landscape: A Virtual Roundtable Discussion

What's Popular?

Abbott Gets FDA EUA for Test That Detects Coronavirus, Three Other Respiratory Infections

Agilent Charges Into Liquid Biopsy Space with Resolution Biosciences Acquisition

Fulgent Genetics Q4 Revenues Skyrocket

T2 Biosystems Q4 Revenues Jump 152 Percent on Strong Product Sales

C2i Genomics Acquires Sequencing Lab QNA Dx

Sponsorships